Leo and the team also saw Gamdias today, focusing on a range of cases, coolers, PSUs and even peripherals. There was ...

A scientific review on autoimmune neurological diseases reveals what occurs in our body when the immune system, by mistake, produces antibodies that target a protein essential for the normal ...

As cyber threats grow faster than organisations can adapt, 2026 is shaping up to be the year when digital resilience becomes the true measure of operational survival ...

Do you experience a welter of detail in many sensory modalities at once? If so, the Global Workspace Theory of consciousness ...

Chloë Grace Moretz's short-lived Prime Video sci-fi series The Peripheral was cancelled after one season, leaving behind so ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get the AARP Now app. New and improved, it’s the app that makes ...

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

On the heels of STRIDE, one of the first trials to show glucagon-like peptide-1 (GLP-1) receptor agonists can help patients with PAD, a retrospective study of more than 100,000 patients provides more ...

We're now closer to being able to diagnose the most common form of dementia with a simple test. The Food and Drug Administration on May 16 said it cleared the first blood test for Alzheimer's disease.